A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/282 (2006.01) A61K 31/337 (2006.01) A61K 31/675 (2006.01) A61K 38/19 (2006.01) A61K 38/20 (2006.01) A61P 35/00 (2006.01) C07K 16/30 (2006.01) C07K 19/00 (2006.01)
Patent
CA 2412845
Disclosed are methods and compositions for treating tumors. Disclosed methods and compositions enhance the uptake of immunocytokines into tumors, and are based on a combination of an immunocytokine with an immunocytokine uptake enhancing agent. Disclosed methods and compositions are particularly useful for reducing tumor size and metastasis in a mammal.
La présente invention concerne des méthodes et des compositions destinées à la cancérothérapie. Ces méthodes et ces compositions améliorent la fixation des immunocytokines sur les tumeurs, et reposent sur une association d'immunocytokines et d'agent améliorant la fixation des immunocytokines. Ces méthodes et ces compositions sont particulièrement utiles dans la réduction de la taille des tumeurs et des métastases chez les mammifères.
Gillies Stephen D.
Holden Sylvia A.
Lan Yan
Fetherstonhaugh & Co.
Lexigen Pharmaceuticals Corp.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Enhancement of antibody-cytokine fusion protein mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhancement of antibody-cytokine fusion protein mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of antibody-cytokine fusion protein mediated... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1859575